Cantargia AB (publ) (STO:CANTA)
Sweden · Delayed Price · Currency is SEK 1.806
+0.016 (0.89%)
Sep 2, 2026, 5:29 PM CET
Cantargia AB Market Cap
Cantargia AB has a market cap or net worth of 448.99 million as of September 2, 2026. Its market cap has decreased by -31.33% in one year.
Market Cap
448.99M
Enterprise Value
227.04M
Revenue
317.31M
Ranking
n/a
PE Ratio
2.70
Stock Price
1.81
ChartMarket Cap Chart
Since March 17, 2015, Cantargia AB's market cap has increased from 120.55M to 448.99M, an increase of 272.44%. That is a compound annual growth rate of 12.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 448.99M | -56.85% |
| Dec 30, 2025 | 1.04B | 147.63% |
| Dec 30, 2024 | 420.15M | -38.81% |
| Dec 29, 2023 | 686.62M | 33.50% |
| Dec 30, 2022 | 514.32M | -72.19% |
| Dec 30, 2021 | 1.85B | -68.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AlzeCure Pharma AB | 1.02B |
| Infant Bacterial Therapeutics AB | 863.52M |
| Oncopeptides AB | 755.00M |
| FluoGuide | 557.51M |
| Xspray Pharma AB | 476.06M |
| Mendus AB | 464.20M |
| Corline Biomedical AB | 427.28M |
| Intervacc AB | 361.26M |